Home Cart Sign in  
Chemical Structure| 869884-78-6 Chemical Structure| 869884-78-6

Structure of Radezolid
CAS No.: 869884-78-6

Chemical Structure| 869884-78-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Radezolid is an oxazolidinone antibiotic agent.

Synonyms: RX-1741; Rx-01_667

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Radezolid

CAS No. :869884-78-6
Formula : C22H23FN6O3
M.W : 438.45
SMILES Code : CC(NC[C@H]1CN(C2=CC=C(C3=CC=C(CNCC4=CN=NN4)C=C3)C(F)=C2)C(O1)=O)=O
Synonyms :
RX-1741; Rx-01_667
MDL No. :MFCD22628873

Safety of Radezolid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00646958 Infectious Skin Diseases ... More >> Bacterial Skin Diseases Staphylococcal Skin Infections Streptococcal Infections Abscess Less << Phase 2 Completed - United States, Alabama ... More >> Drug Research & Analysis Corp Montgomery, Alabama, United States United States, California OWENS Pharma Research Center Long Beach, California, United States Healthcare Partners Medical Group Los Angeles, California, United States HealthCare Partners Medical Group Pasadena, California, United States Olive View- UCLA Center, Dept. Emergency Medicine Sylmar, California, United States United States, Florida South Florida Clinical Research Atlantis, Florida, United States United States, Georgia Southeast Regional Research Group Columbus, Georgia, United States Contemporary Medicine, LLC Hinesville, Georgia, United States United States, Indiana Infectious Disease of Indiana, PSC. Indianapolis, Indiana, United States United States, Louisiana Clinical Trials of America, Inc. Shreveport, Louisiana, United States United States, Michigan Arnold Markowitz, MD., PC Keego Harbor, Michigan, United States United States, Montana Mercury Street Medical Group, LLC Butte, Montana, United States United States, New York Jamaica Hospital Medical Center Jamaica, New York, United States United States, North Carolina ALL-TRIALS Clinical Research, LLC Winston-Salem, North Carolina, United States United States, Ohio Summa Health System Akron, Ohio, United States United States, Pennsylvania Brandywine Clinical Research Downington, Pennsylvania, United States Warminster Medical Associates, P.C. Warminster, Pennsylvania, United States United States, Tennessee McKenzie Medical Center McKenzie, Tennessee, United States United States, Utah J. Lewis Research, Inc. Salt Lake City, Utah, United States Less <<
NCT00646958 - Completed - -
NCT00640926 - Completed - -
NCT00640926 Community-Acquired Pneumonia (... More >>CAP) Less << Phase 2 Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.28mL

0.46mL

0.23mL

11.40mL

2.28mL

1.14mL

22.81mL

4.56mL

2.28mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories